Sales & Marketing Views & Analysis

Views & Analysis

UK Leaders: Gilead's Hilary Hutton-Squire on building trust ...

As general manager of Gilead UK and Ireland, Hilary Hutton-Squire has been at the forefront of bringing several innovative medicines to the NHS.

Views & Analysis

Coronavirus pharma conference monitor – event impact of COVI...

The COVID-19 coronavirus epidemic that originated in Wuhan, the capital of China’s Hubei province, has wide-ranging implications for the pharmaceutical industry and healthcare sector alike.

Sales & Marketing

How pharma can adapt to climate change

Climate change is perhaps the most complex issue facing modern society, affecting every aspect of human life including our health.

Views & Analysis

Does pharma’s future lie in China?

Healthcare innovation has a long history in effective collaboration, whether that’s across academia and industry or borders.

Views & Analysis

Customer experience in pharma: Getting the journey right

As part of a series of interviews in partnership with Indegene focusing on the customer experience in pharma, AstraZeneca’s global consumer marketing director Melissa Fellner tells Paul

Views & Analysis

UK leaders: Takeda’s Jon Neal

In the first of a new series where we talk to GMs of UK pharma divisions, managing director for Takeda UK & Ireland, Jon Neal, tells us about the Shire acquisition, rare diseases, a

UK Leaders: Gilead's Hilary Hutton-Squire on building trust ...

Coronavirus pharma conference monitor – event impact of COVI...

How pharma can adapt to climate change

Does pharma’s future lie in China?

Customer experience in pharma: Getting the journey right

UK leaders: Takeda’s Jon Neal

CMS aims for broader GLP-1 access via federal programmes

How to meet your physicians where they are online

Views & Analysis

Editor's Picks